UNDERVALUEDNASDAQ · Healthcare

Rani Therapeutics Holdings, Inc.

RANI

FAIR PRICE VALUATION

15.3%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$0.79

FAIR PRICE

$0.91

MARGIN

$0.12

UNDERVALUEDFAIROVERVALUED

P/E Ratio

N/A

Div. Yield

N/A

ROE

-718.5%

Average

Market Cap

$48M

Small-cap

COMING SOON

Get notified when RANI's fair price changes

Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.

iOS and Android · Free tier available

KEY FACTS

CEO

Talat Imran

COUNTRY

US

HEADQUARTERS

San Jose

SECTOR

Healthcare

EXCHANGE

NASDAQ

METHODOLOGY

How we calculate RANI's fair price

Rani Therapeutics Holdings, Inc.'s fair price of $0.91 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.79, RANI trades 15.3% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting RANI's risk profile.

RELATIVE · 30%

Comparing RANI's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for RANI, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate RANI's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for RANI.

Explore on Bulios

FAQ

What is the fair price of RANI?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Rani Therapeutics Holdings, Inc. is $0.91. At the current market price of $0.79, RANI trades 15.3% below its calculated fair value.

Is RANI overvalued or undervalued?+

Rani Therapeutics Holdings, Inc. is currently undervalued based on our valuation model. The stock trades at $0.79, which is 15.3% below the fair price of $0.91.

How often is RANI's fair price updated?+

We update fair price calculations for RANI daily after market close. The current fair price of $0.91 incorporates the latest market data and sector multiples.

What factors affect RANI's fair price calculation?+

RANI's fair price of $0.91 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -718.5%.

Is RANI a good buy right now?+

At $0.79, RANI trades 15.3% below our fair value estimate of $0.91. The stock is currently undervalued. ROE stands at -718.5% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does RANI pay dividends?+

RANI does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.